Clinical Trial Update: Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating omega-3 fatty acid lipidomics in diabetic peripheral neuropathy. The study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Iowa | Conditions: Diabetic Neuropathies | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING